PDB113 Intensification of Basal Insulin Treatment Among Patients With Diabetes Mellitus Type 2 In The Netherlands  by Overbeek, J et al.
 VA L U E  I N  H E A LT H  1 8  ( 2 0 1 5 )  A 3 3 5 – A 7 6 6  A617
more (n= 2), and it caused a reduction in glycosylated hemoglobin (HbA1c) (n= 4). 
The impact of TTM on medication adherence is still unknown. ConClusions: TTM 
helps type 2 diabetic patients self-manage their condition, and to reach their goals, 
hence achieving better clinical outcomes, and quality of life.
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objeCtives: To characterise type 2 diabetes (T2DM) patients in the Netherlands 
initiating basal insulin and those intensifying treatment. Methods: Antidiabetic 
dispensing records were obtained from the Out-patient Pharmacy Database of the 
PHARMO Database Network. New users, i.e. first-time dispensing, of basal insu-
lin only were selected between 2007-2012. Treatment intensification was defined 
as either add-on of GLP-1, bolus insulin or DPP-4i or switch to premixed insulin. 
Demographics and HbA1c before basal insulin start (pre-insulin), at intensification 
and post- intensification were assessed including time to intensification. Results: 
A total of 15,986 T2DM patients initiating basal insulin only (median (IQR) age at start 
basal insulin: 65 (55-74) years, 52% male, 87%, 75% and 51% had a pre-insulin HbA1c 
> 53, > 58 and > 64 mmol/mol, respectively). Overall, 4,945 patients (31%) intensified 
treatment during a median follow-up of 14 months (median (IQR) age at start basal 
insulin: 63 (53-73) years, 50% male, 88%, 78% and 54% had an HbA1c at intensifica-
tion > 53, > 58 and > 64 mmol/mol, respectively). Intensification mostly was add-on 
of bolus insulin (58%) or switch to premixed insulin (39%). Median (IQR) time to 
intensification was 8 (2-15) months. Among patients with an HbA1c > 53, > 58 and 
> 64 mmol/mol at intensification, median (IQR) time to intensification was 12 (5-23), 
12 (5-22) and 12 (5-22) months, respectively. Post-intensification, 32%, 52% and 73% 
of the patients attained an HbA1c of ≤ 53, ≤ 58 and ≤ 64 mmol/mol, respectively, 
with median reduction in HbA1c of 6 mmol/mol. ConClusions: About one third 
of T2DM patients initiating basal insulin intensified their treatment leading to gly-
cemic goal attainments of HbA1c ≤ 53, ≤ 58 and ≤ 64 mmol/mol in 32%, 52% and 73% 
of patients, respectively. Further research might provide more information on the 
underlying reasons and potential barriers for intensifying versus not intensifying, 
such as patient characteristics, co-medication, treatment complexity and occur-
rence of hypoglycaemic events.
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objeCtives: To evaluate the clinical and the economic outcomes of a personalized 
care model (PCM) in diabetes mellitus (DM) supported by information and communi-
cations technology (ICT) in the Spanish National Health System (NHS). Methods: 
We evaluated a PCM in DM proposed by a group of European experts based on 6 
steps: 1.Structured education; 2.Structured self-monitoring of blood glucose (SMBG); 
3.Structured documentation; 4.Structured data analysis; 5.Personalized treatment; 
6.Evaluation of results. A literature review was made to assess the results of inter-
ventions made within the NHS that used the PCM described. Interventions evaluat-
ing type 2 DM (T2DM), type 1 DM (T1DM) and gestational DM were included. The 
health outcomes measured were the variation in HbA1c,the percentage of controlled 
patients, the body mass index and the body weight. The analysis was made from the 
payer’s perspective, considering the direct costs related to the pathology (€ 2015). 
Costs evaluated were: hospital costs, outpatient visits costs, primary care costs, 
emergency care costs and SMBG costs. Results: The review carried out showed 
that the introduction of this PCM in T2DM would result in an increase of up to 18% 
in controlled patients (HbA1c% < 7%) compared with the current model (follow-
up of 12 months). The expected reduction in HbA1c%would be about -0.5%. The 
implementation of the PCM proposed would reduce the cost of T2DM by about 12% 
compared with the current model with reductions of up to 30% in the cost for out-
patient visits. The expected reduction in total direct costs was approximately 12% 
in T1DM and around 14% in gestational DM. ConClusions: The implementation 
of a PCM in DM with ICT support improved or provided equal disease control com-
pared with conventional care and reduced the high costs associated with diabetes. 
ICT enables adaption and changes in the current model of care and potentiate 
self-management strategies.
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objeCtives: To identify, describe in detail, and assess the evidence regarding the 
effects of Diabetes Conversation Maps™, an educational tool that engages diabetic 
patients in group discussions about diabetes-related topics, over a range of patient 
outcomes. Methods: We conducted a systematic literature review of articles 
published since 2005 that evaluated the Maps™ since 2005 using five electronic 
databases, and the reference lists of relevant papers. Non-English languages, non-
journal papers, and studies that only included a description of the Maps™ were 
excluded. A quality assessment of relevant studies was performed. Outcomes were 
grouped into: objective (e.g., HbA1c levels), subjective (e.g., self-efficacy), and health 
behaviors (e.g., medication adherence). Results: Of the 62 studies originally identi-
fied, 13 were included in the final sample. The overall methodological quality of the 
sion analysis was employed to assess impact of socioeconomic,demographic and 
disease- specific variables on WTP for QALY. Results: Totally, 149 patients with 
type 1 and 2 diabetes were included in analysis. Types 1 were younger with higher 
probability of hospitalization and longer diabetes duration. Foot diabetic disease, eye 
disease and hypertensive were the main comorbidities in both types, accordingly. 
Mean willingness to pay per QALY were estimated between 58,982,210-124,675,610 
IRR (Iranian Rials) that is equal 2107-4453 US Dollars. Significantly, patients with 
better health state, higher cost group (as a proxy of income) and inpatients admis-
sion had higher WTP for QALY. ConClusions: Mean WTP per QALY are between 
0.44-.93 times of local Gross Domestic Product (GDP) per capita. According to rec-
ommendation of world health organization on using 1-3 time GDP per capita as a 
threshold value and defined cost-effectiveness categories, our findings, although, 
is closed to one, but do not advocate strongly the proposed range by WHO. Thus, in 
decision making and resource allocation process, WHO recommendation should be 
employed with cautious and more investigation.
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objeCtives: Mobile phone SMS is increasingly used as a means of communication 
between patients and their healthcare providers in many countries of the world.We 
investigated mobile phone use and factors associated with willingness-to-pay (WTP) 
for diabetes SMS among patients with type 2 diabetes in Bangladesh. Methods: 
As part of a randomized controlled study, in 515 patients with type 2 diabetes, 
socioeconomic status, mobile phone use, WTP for diabetes SMS, anthropometry and 
HbA1c were measured. Multivariate regression was used to identify factors associ-
ated with WTP. Results: The median (interquartile range [IQR]) of WTP for diabetes 
SMS was 20 (45) Bangladesh Taka (BDT) (1 BDT ¼ 0.013 US$). WTP was significantly 
higher for males [OR 2.4, 95% CI (1.0–5.7)], patients with household income .50 000 
BDT [4.6 (1.1–20.4)] and those with primary education [5.6 (1.2–26.6)] and secondary 
and higher education [5.2 (1.4–19.6)]. ConClusions: The high proportion of mobile 
phone use and WTP for diabetes SMS are encouraging as possible strategy to use 
such technologies and deserve further evaluation.
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objeCtives: The aim of this study was to estimate willingness to pay (WTP) amount 
for one quality adjusted-life years (QALY) in diabetic patients and investigating fac-
tors that associated with it. Methods: A cross sectional survey with face to face 
interviews was conducted with diabetic patients in Tehran city between June and 
August of 2014 to elicit WTP for QALY as following: First, Current health preferences 
were measured using EuroQol-5D (EQ-5D), visual analogue Scale (VAS) and time 
trade off (TTO) techniques, then a hypothetical scenario using double bounded 
dichotomous choice technique was presented to patients to elicit individual’s maxi-
mum WTP for a treatment that recovering them to full health ,contingent to be 
available. So value of QALY was estimated by combining preferences. A regression 
analysis was employed to investigate impact of individuals’ characteristics and 
disease- specific variables on the WTP for QALY. Results: Totally, 149 patients with 
type 1 and 2 diabetes were included in analysis. Types 1 were younger with higher 
probability of hospitalization and longer diabetes duration. Foot diabetic disease, eye 
disease and hypertensive were the main comorbidities in both types, accordingly. 
Mean willingness to pay per QALY were estimated between 58,982,210-124,675,610 
IRR (Iranian Rials) that is equal 2107-4453 US Dollars. Significantly, patients with bet-
ter health state, higher cost group (as a proxy of income) and inpatients admission 
had higher WTP for QALY. ConClusions: Mean WTP per QALY are between 0.44-.93 
times of local Gross Domestic Product (GDP) per capita. According to recommenda-
tion of world health organization on using 1-3 time GDP per capita as a threshold 
value and defined cost-effectiveness categories, our findings, although, is closed to 
one GDP per capita, but do not advocate strongly the proposed range by WHO. Thus, 
in decision making and resource allocation process, WHO recommendation should 
be employed with cautious and more investigation.
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objeCtives: The objective of this study is to assess the use of transtheoretical model 
(TTM) in improving self-management activities in type 2 diabetic patients. Self-
management activities include following a healthier diet, exercising more regularly, 
and an enhanced medication adherence. Methods: Pubmed, Medline, Science 
direct, and Cochrane databases were searched with predefined terms relating to 
TTM interventions for type 2 diabetic patients. All study designs were included. 
The systematic search was conducted in March 2015. Two reviewers independently 
assessed the relevance of abstracts identiﬁed, extracted the data and undertook 
quality analysis. The review was done using PRISMA checklist. Results: Ten studies 
met the criteria for inclusion in the review. All studies demonstrated some positive 
outcomes self-management due to implementing TTM. In six studies the patients 
reached the action or maintenance stage in the TTM cycle after the TTM interven-
tion. Moreover, TTM was able to help patients follow a healthier diet (n= 5), exercise 
